Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo

International Immunology

Volumn 11, Issue 5, 1999, Pages 667-675

  Metzler, Barbara ^b   Burkhart, Christoph ^a   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD28; CTLA 4; Phenotypic analysis; T cell activation

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLAST CELL; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOREGULATION; IN VIVO STUDY; KINETICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0032965160     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.5.667     Document Type: Article

References (55)

1. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
2. Chambers, C. A. and Allison, J. P. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396.
3. Thompson, C. B. and Allison, J. P. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
4. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
5. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
6. Krummel, M. F. and Allison, J. P. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
7. Krummel, M. F., Sullivan, T. J. and Allison, J. P. 1996. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 8:519.
8. Krummel, M. F. and Allison, J. P. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
9. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
10. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 270:985.
11. Tivol, E. A., Boriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., Sharpe, A. H. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
12. Chambers, C. A., Cado, D., Truong, T. and Allison, J. P. 1997. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl Acad. Sci. USA 94:9296.
13. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
14. Kuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
15. Perrin, P. J., Scott, D., June, C. H. and Racke, M. K. 1995. B7-mediated costimulation can either provoke or prevent clinical manifestation of experimental allergic encephalomyelitis. Immunol. Res. 14:189.
16. Miller, S. D. and Bluestone, J. A. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
17. Leach, D. R., Krummel, M. F. and Allison, J. P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
18. Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B. and Allison, J. P. 1997. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl Acad. Sci. USA 94:8099.
19. McCoy, K., Camberis, M. and Le Gros, G. 1997. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 186:183.
20. Karandikar, N. J., Vanderlugt, C. L., Eagar, T., Tan, L., Bluestone, J. A. and Miller, S. D. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:192.
21. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. and Khoury, S. 1998. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104.
22. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
23. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D. and Wraith, D. C. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
24. Chen, Y., Inobe, J.-i., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
25. + T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335.
26. Lespagnard, L., Mettens, P., De Smedt, T., Bazin, H., Urbain, J., Leo, O. and Moser, M. 1998. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. Int. Immunol. 10:295.
27. Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B. and Abbas, A. K. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
28. Van Parijs, L., Perez, V. L., Biuckians, A., Maki, R. G., London, C. A. and Abbas, A. K. 1997. Role of interleukin 12 and costimulators in T cell anergy in vivo. J. Exp. Med. 186:1119.
29. Samoilova, E. B., Norton, J. L., Zhang, H., Khoury, S. J., Weiner, H. L. and Chen, Y. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10:491.
30. Gross, J. A., Callas, E. and Allison, J. P. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
31. Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C. and Damle, N. K. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
32. Leung, H. T., Bradshaw, J., Cleaveland, J. S. and Linsley, P. S. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270:25107.
33. Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennet, K. L. and Mittler, R. S. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4:535.
34. Alegre, M.-L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L. and Thompson, C. B. 1996. Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157:4762.
35. Metzler, B. and Wraith, D. C. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1159.
36. Liu, G. Y. and Wraith, D. C. 1995. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice - implications for autoimmunity. Int. Immunol. 7:1255.
37. Anderton, S. M. and Wraith, D. C. 1998. Hierarchy in the ability of T cell epitopes to induce tolerance to antigens from myelin. Eur. J. Immunol. 28:1251
38. Liu, G. Y. 1995. Tolerance induction in an experimental model of autoimmunity. PhD thesis, Cambridge University, Cambridge, UK.
39. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. and McDevitt, H. O. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247.
40. Zamvil, S. S., Mitchell, D. J., Moore, A. C., Kitamura, K., Steinman, L. and Rothbard, J. B. 1986. T cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
41. Fairchild, P. J., Wildgoose, R., Atherton, E., Webb, S. and Wraith, D. C. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
42. u, which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 2:181.
43. h2 cells. J. Immunol. 161:3347.
44. Linsley, P. S., Bradshaw, J., Urnes, M., Grosmaire, L. and Ledbetter, J. A. 1993. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J. Immunol. 150:3161.
45. Cefai, D., Schneider, H., Matangkasombut, O., Kang, H., Brody, J. and Rudd, C. E. 1998. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J. Immunol. 160:2223.
46. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. and Loh, D. Y. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
47. Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B. and Bluestone, J. A. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
48. low subset. J. Exp. Med. 172:1701.
49. + T cell subset that inhibits autoimmune potential. J. Exp. Med. 177:627.
50. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
51. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). J. Immunol. 155:1151.
52. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
53. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212.
54. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
55. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. and Penit, C. 1998. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.